An α-cyperone derivative, its preparation method and application
By carrying out oxime derivatization, halogen substitution and oxidative aldehyde hydration reactions on α-cyperone, a highly efficient α-cyperone derivative was prepared, which solved the problem of insufficient antibacterial activity of α-cyperone in agricultural applications and achieved a significant antibacterial effect against a variety of plant pathogens.
Patent Information
- Application Number
- CN202611092545.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-07-22
- Publication Date
- 2026-11-17
AI Technical Summary
The existing α-cyperone has weak antibacterial activity in agricultural applications and cannot be used in actual production.
α-Cyperone derivatives, such as oxime esters, halogenated derivatives, and aldehyde derivatives, were prepared by oxime derivatization, halogen substitution, and oxidative aldehyde alkylation reactions, thereby enhancing its antibacterial activity in agriculture.
The prepared α-cyperone derivatives showed significant antibacterial activity against tomato gray mold, tomato early blight, tomato skin rot Fusarium, watermelon wilt, wheat scab, and millet blast fungus. Some derivatives showed antibacterial activity superior to commercial fungicides.
Smart Images

Figure CN123106471A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of agricultural fungicide technology, specifically to an α-cyperone derivative and its preparation method and application. Background Technology
[0002] α-Cyperone is a compound mainly derived from the noxious weed Cyperus rotundus (Cyperus rotundus). Cyperus rotundus Typical eucalyptane-type sesquiterpenoids in *Drosophila melanogaster* (L.) not only possess various pharmacological activities such as anti-inflammatory, antioxidant, and antidepressant effects, but also exhibit significant potential for agricultural antibacterial and insecticidal applications. Among them, the literature [Julio A, Claudio L, Carlos LC, 2013. Insecticidal activity of sesquiterpenekeleton synthesized by the conventional robinson annulations reaction on *Drosophila melanogaster*. Industrial Crops and Products, 42: 268-272] reports the insecticidal activity of α-cyperone against *Drosophila melanogaster*. The literature [Liu CX, Lu NX, Liu ZQ, et al., 2016. Chemical composition and insecticidal activity of the essential oil of cyperus rotundus rhizomes against liposcelis bostrychophila (Psocoptera: Liposcelididae). Journal of Essential Oil BearingPlants, 19(3): 640-647] found that α-cyperone is effective against the storage pest book-boring rodent (Psocoptera: Liposcelididae). Liposcelis bostrychophila BadonnelIt has good contact toxicity. The literature [Hao Donglin, 2016. Study on antioxidant, antibacterial activity and antibacterial mechanism of Cyperus rotundusrhizomes essential oil. Taiyuan: Shanxi Normal University] and the literature [Luo MJ, Qiu JZ, Zhang Y, et al., 2012. α-cyperone alleviates lung cell injury caused by staphylococcus aureus via attenuation of α-hemolysin expression. Journal of Microbiology and Biotechnology, 22(8): 1170-1176] and [Hu QP, Cao XM, Hao DL, et al., 2017. Chemical composition, antioxidant, DNA damage protective, cytotoxic and antibacterial activities of Cyperus rotundusrhizomes essential oil against foodborne pathogens. Scientific Reports, 7(1): 45231] reported that α-cyperone has good contact toxicity against Staphylococcus aureus ( Staphylococcus aureus ) and Bacillus subtilis ( Bacillus subtilis It has a strong inhibitory effect on various foodborne pathogens such as α-cyperone. The literature [Zhang LY, Lv S, Wu SC, et al., 2014. Inhibitory effects of α-cyperone on adherence and invasion of avianpathogenic Escherichia coli O78 to chicken type II pneumocytes. Veterinary Immunology and Immunopathology, 159(1-2): 50-57] revealed the inhibitory activity of α-cyperone on pathogenic Escherichia coli in poultry; the literature [Horn C and Vediyappan G, 2021. Anticapsular and antifungal activity of α-cyperone. Antibiotics, 10(1): 51] reported that α-cyperone can significantly inhibit Cryptococcus neoformans (Cryptococcus neoformans). Cryptococcus neoformansThe biosynthesis of key virulence factors in the capsule effectively reduces capsule thickness, thereby exerting its antibacterial activity.
[0003] The research results from the above literature show that α-cyperone has significant inhibitory activity against a variety of pathogenic microorganisms. However, compared with mainstream commercial antibacterial agents, its agricultural antibacterial activity is weak and cannot be applied to actual production. Its antibacterial potential still has considerable room for improvement. Summary of the Invention
[0004] The purpose of this invention is to solve the problem that α-cyperone has weak antibacterial activity in agricultural applications and cannot be applied to actual production in the prior art.
[0005] To achieve the above objectives, the technical solution adopted by the present invention is as follows: This invention provides an α-cyperone derivative, which is selected from any one of the oxime derivatization products, halogen-substituted products, and aldehyde-substituted products of α-cyperone.
[0006] Furthermore, the oxime derivatization products include oxime ethers and oxime esters; the oxime esters are carboxylic acid oxime esters, sulfonic acid oxime esters, carbamate oxime esters, and thiocarbamate oxime esters.
[0007] Furthermore, the halogen-substituted products are chlorinated or brominated derivatives.
[0008] Furthermore, the general chemical formula of α-cyperone derivatives is shown in formula (I): Equation (I) Formula (I)R 1 It is any one of the following: In equation (Ⅰ), R 1 and R 2 It is any of the following: This invention also provides a method for preparing α-cyperone derivatives, using α-cyperone as a starting material, and obtaining α-cyperone derivatives through at least one of the following three types of reactions: Oxime derivatization reaction: First, α-cyperone is oximated to obtain α-cyperone oxime intermediate, and then the intermediate is esterified or etherified to prepare various oxime esters and oxime ether derivatives. Oxidative aldehyde reaction: The oxidant directly oxidizes the α-cyperone core to obtain aldehyde derivatives; Halogenation substitution reaction: α-Cyperone undergoes substitution with halogenated reagents to yield chlorinated and brominated derivatives.
[0009] Further, the oxime derivatization reaction steps are as follows: using an alcohol solvent, α-cyperone reacts with hydroxylamine hydrochloride to obtain an α-cyperone oxime intermediate; using an organic base in combination with a haloalkane solvent, the intermediate reacts with substituted acyl chlorides and sulfonyl chlorides to obtain carboxylic acid oxime ester derivatives C1–C4 and sulfonate oxime ester derivatives C5–C8; using a strong base in combination with an ether solvent, the intermediate reacts with a haloalkane to obtain α-cyperone oxime ether derivatives C9–C11; using a ketone solvent, the intermediate condenses with substituted isocyanates and isothiocyanates to obtain carbamate oxime ester derivatives C12–C15 and thiocarbamate oxime ester derivatives C16–C18, respectively. The oxidative aldehyde reaction steps are as follows: using 1,4-dioxane as a solvent, selenium dioxide oxidizes α-cyperone to obtain the aldehyde derivative C19; The halogenation substitution reaction steps are as follows: α-Cyperone reacts with trichloroisocyanuric acid in tetrahydrofuran as a solvent to prepare chloro-α-cyperone C20; α-Cyperone reacts with... N -Brominated succinimide reaction to prepare bromo derivative C21.
[0010] Preferably, the organic base is triethylamine, the haloalkane solvent is dichloromethane, the strong base is sodium hydride, the ether solvent is tetrahydrofuran, and the ketone solvent is acetone.
[0011] Furthermore, a method for preparing an α-cyperone derivative is characterized by specifically including the following steps: 1.0 mmol of α-cyperone, 3.0 mmol of hydroxylamine hydrochloride, and 12.5 mmol of pyridine were dissolved in anhydrous ethanol and reacted at room temperature. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was concentrated under reduced pressure, water was added and stirred, and the pH of the mixture was adjusted to neutral with saturated sodium bicarbonate solution. The mixture was extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain the α-cyperone oxime intermediate. 0.5 mmol of α-cyperone oxime intermediate and 1.5 mmol of triethylamine were dissolved in anhydrous dichloromethane. 0.6 mmol of the corresponding substituted acyl chloride or sulfonyl chloride was slowly added dropwise. The reaction was stirred at room temperature, and the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction solution was concentrated under reduced pressure. The residue was purified by preparative thin-layer chromatography to obtain α-cyperone carboxylic acid oxime ester derivatives C1–C4 or sulfonate oxime ester derivatives C5–C8. 0.5 mmol of the α-cyperone oxime intermediate was dissolved in anhydrous tetrahydrofuran, and 2.0 mmol of sodium hydride was added and stirred at room temperature. Then, 2.0 mmol of the corresponding haloalkane was added to the reaction solution and reacted under reflux. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was naturally cooled to room temperature, concentrated under reduced pressure to remove the solvent, water was added to the residue and stirred, and the pH of the mixture was adjusted to neutral with 1 M dilute hydrochloric acid aqueous solution. The mixture was then extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and purified by preparative thin-layer chromatography to obtain α-cyperone oxime ether derivatives C9–C11. 0.5 mmol of α-cyperone intermediate was dissolved in acetone, and 0.6 mmol of the corresponding substituted isocyanate or isothiocyanate was added to the reaction solution. The reaction was stirred under reflux, and the reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was naturally cooled to room temperature, and the solvent was removed by concentration under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain carbamate oxime derivatives C12–C15 or thiocarbamate oxime derivatives C16–C18. 0.5 mmol of α-cyperone and 0.8 mmol of selenium dioxide were stirred in 1,4-dioxane at room temperature. After the reaction was completed, the reaction solution was concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain aldehyde compound C19. 0.5 mmol of α-cyperone and 0.5 mmol of trichloroisocyanuric acid were dissolved in anhydrous tetrahydrofuran and stirred at -15°C. After the reaction was complete, the reaction solution was concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain chloro-α-cyperone C20. 0.5 mmol of α-cyperone and N 0.8 mmol of α-bromosuccinimide was refluxed in anhydrous dichloromethane. After the reaction was complete, the reaction solution was cooled to room temperature, concentrated under reduced pressure to remove the solvent, and the residue was purified by preparative thin-layer chromatography to obtain α-bromocyperone C21.
[0012] The present invention also provides an application of α-cyperone derivatives, wherein α-cyperone derivatives or pharmaceutically acceptable salts thereof can be used in the preparation of bactericides.
[0013] Furthermore, the fungicide can be used against any one of the following plant pathogenic fungi: Botrytis cinerea, Early blight fungus, Fusarium solani, Fusarium wilt fungus, Fusarium graminearum, or Fusarium blast fungus.
[0014] Compared with the prior art, the present invention has the following beneficial effects: This invention uses α-cyperone as a raw material to prepare α-cyperone derivatives. The compounds involved in this invention exhibit good antifungal activity against *Botrytis cinerea*, *Early Blight*, *Fusarium solani*, *Fusarium wilt*, *Fusarium graminearum*, and *Fragaria graminearum*. Specifically, some derivatives show significantly higher mycelial growth inhibition activity against these six plant pathogens than the commercial fungicide oxadixyl, and some derivatives show significantly better spore germination inhibition activity against *Botrytis cinerea*, *Early Blight*, *Fusarium solani*, and *Fusarium graminearum* than the commercial fungicide difenoconazole. Therefore, the α-cyperone derivatives of this invention hold promise for development into highly efficient and broad-spectrum novel agricultural fungicides. Attached Figure Description
[0015] Figure 1 The 1H NMR spectrum of compound C1; Figure 2 The 1H NMR spectrum of compound C20. Detailed Implementation
[0016] The present invention will be further described below with reference to the accompanying drawings and specific embodiments.
[0017] Preparation routes, methods, and structural characterization data of α-cyperone derivatives C1–C21 The following is the preparation route for derivatives C1–C18: Synthetic method of intermediate α-cyperone oxime B: 1.0 mmol of α-cyperone A, 3.0 mmol of hydroxylamine hydrochloride, and 12.5 mmol of pyridine were dissolved in 3 mL of anhydrous ethanol and reacted at room temperature. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was concentrated under reduced pressure, 20 mL of water was added and stirred, and the pH of the mixture was adjusted to neutral with saturated sodium bicarbonate solution. The mixture was extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain α-cyperone oxime B.
[0018] Preparation methods of C1–C4 carboxylic acid oxime ester derivatives and C5–C8 sulfonic acid oxime ester derivatives: Intermediate B (0.5 mmol) and triethylamine (1.5 mmol) were dissolved in 3 mL of anhydrous dichloromethane. The corresponding substituted acyl chloride (0.6 mmol) or substituted sulfonyl chloride (0.6 mmol) was slowly added to the mixture, and the reaction was stirred at room temperature. The reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the solvent was removed by concentration under reduced pressure. The residue was purified by preparative thin-layer chromatography to obtain α-cyperone carboxylic acid oxime derivatives C1–C4 and α-cyperone sulfonic acid oxime derivatives C5–C8, respectively.
[0019] Preparation steps of C9–C11 oxime ether derivatives: Intermediate B 0.5 mmol was dissolved in 3 mL of anhydrous tetrahydrofuran, and 2.0 mmol of sodium hydride was added. The mixture was stirred at room temperature for 10 min. Then, 2.0 mmol of the corresponding haloalkane was added to the reaction solution, and the reaction was carried out under reflux. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was cooled to room temperature and concentrated under reduced pressure to remove the solvent. 20 mL of water was added and stirred. The pH of the mixture was adjusted to neutral with 1 M HCl aqueous solution, and then extracted with ethyl acetate. The combined organic phases were dried over anhydrous sodium sulfate, and the residue obtained after concentration under reduced pressure was purified by preparative thin-layer chromatography to give α-cyperone oxime ether derivatives C9–C11.
[0020] Synthetic steps for carbamate oxime compounds (C12–C15) and thiocarbamate oxime derivatives (C16–C18): Intermediate B (0.5 mmol) was dissolved in 3 mL of acetone. 0.6 mmol of the corresponding substituted isocyanate or substituted isothiocyanate was added to the reaction solution, and the mixture was stirred under reflux. The reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction solution was allowed to cool naturally to room temperature, and then concentrated under reduced pressure to remove the solvent. The crude product was purified by preparative thin-layer chromatography to obtain α-cypermethrin carbamate oxime derivatives C12–C15 and thiocarbamate oxime derivatives C16–C18, respectively.
[0021] The following is the preparation route for derivatives C19–C21: Synthetic methods for aldehyde compound C19: 0.5 mmol of α-cyperone A and 0.8 mmol of selenium dioxide were reacted in 3 mL of 1,4-dioxane at room temperature with stirring. After the reaction was complete, the reaction solution was concentrated under reduced pressure, and the crude product was purified by preparative thin-layer chromatography to obtain aldehyde compound C19.
[0022] Preparation method of chloro-α-cyperone C20: 0.5 mmol of α-cyperone A and 0.5 mmol of trichloroisocyanuric acid were reacted in 3 mL of anhydrous tetrahydrofuran at -15 °C with stirring. After the reaction was complete, the reaction solution was concentrated under reduced pressure, and the crude product was purified by preparative thin-layer chromatography to obtain chloro-α-cyperone C20.
[0023] Synthetic method of bromo-α-cyperone C21: α-Cyperone A 0.5 mmol and N 0.8 mmol of α-bromosuccinimide was refluxed in 3 mL of anhydrous dichloromethane. After the reaction was complete, the reaction solution was concentrated under reduced pressure, and the residue was purified by preparative thin-layer chromatography to obtain α-bromocyperone C21.
[0024] The physicochemical properties of compound C1 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.76 (s, 2H, 12-H), 2.99–3.05 (m, 1H, 2-H), 2.79–2.82 (m, 1H, 2-H), 2.31–2.40 (m, 1H, 7-H), 2.21 (s, 3H, -CO-CH 3) , 1.89–1.98 (m, 5H, 6-H and 15-H), 1.77 (s, 3H, 13-H), 1.58–1.66 (m, 4H, 1-H and 8-H), 1.46–1.54 (m, 1H,9-H), 1.32–1.39 (m, 1H, 9-H), 1.10 (s, 3H, 14-H). – 13 CNMR (100 MHz, CDCl3): d =169.6, 163.7, 153.4, 149.4, 122.2, 109.0, 45.9, 41.7, 36.2, 35.0, 32.0, 27.0, 22.6, 20.7, 20.6, 19.9, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =298.1788 (calcd. 298.1783 for C 17 H 25 NO2Na +, [M+Na] + ). The physicochemical properties of compound C2 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d =6.50–6.54 (m, 1H, Cl -CH2-), 6.24–6.30 (m, 1H, Cl -CH2-C H 2-), 5.88–5.91 (m, 1H, Cl -CH2-), 4.76 (s, 2H, 12-H), 3.01–3.07 (m, 1H, 2-H), 2.80–2.83 (m, 1H, 2-H), 2.35–2.44 (m, 1H, 7-H), 1.99–2.14 (m, 2H,6-H),1.96 (s, 3H, 15-H), 1.89–1.92 (m, 1H, Cl -CH2-C H – 13 C NMR (100 MHz, CDCl3): d = 164.6, 164.0, 153.6, 149.4,131.3, 126.9, 122.3, 109.0, 45.9, 41.7, 36.2, 35.1, 32.0, 27.0, 22.6, 20.7,20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =346.1544 (calcd. 346.1550 for C 18 H 26 NO2Na 35 Cl + [M+H] + ); 348.1514 (calcd.348.1520 for C 18H 26 NO2Na 37 Cl + , [M+Na] + ). The physicochemical properties of compound C3 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d =8.24–8.27 (m, 2H, Ph-H), 7.06–7.11 (m, 2H, Ph-H), 5.75 (s, 1H, H-1), 5.18 (s, 1H, H-12), 4.98 (s, 1H, H-12), 4.16 (d, J =14.0 Hz, 1H, H-13), 4.02 (d, J = 14.0 Hz, 1H, H-13), 2.45–2.58 (m, 2H, H-3), 2.34–2.39 (m, 1H, H-9), 2.21–2.26 (m, 2H, H-9 and H-7), 2.07–2.11 (m, 1H, H-8), 2.00–2.04 (m, 1H, H-8), 1.94–1.99 (m, 1H, H-6), 1.38–1.44 (m, 1H, H-4), 1.09–1.15 (m, 1H, H-6), 1.03 (s, 3H, H-15), 0.87 (d, J = 6.8 Hz, 3H, H-14); – 13 CNMR (100 MHz, CDCl3): d = 199.5, 175.5, 172.8 (( J CF = 297.1 Hz)), 166.7, 164.2,148.0, 132.2 ( J CCCCF = 9.1 Hz), 124.9, 115.2 ( J CCF = 21.5 Hz), 113.3 ( J CCCF= 10.5Hz), 44.5, 42.0, 40.4, 39.5, 37.0, 36.1, 32.9, 32.1, 16.7, 14.8. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =374.1866 (calcd. 374.1863 for C 20 H 30 NO2Na 35 Cl + , [M+Na] + ); 376.1842 (calcd.376.1839 for C 20 H 30 NO2Na 37 Cl + , [M+Na] + ). The physicochemical properties of compound C4 are as follows: 1) Pale yellow solid, melting point 121.3–122.5 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d =8.08–8.10 (m, 2H, Ph-H), 7.56–7.60 (m, 1H, Ph-H), 7.45–7.48 (m, 2H, Ph-H), 4.77 (s, 2H, 12-H), 3.14–3.20 (m, 1H, 2-H), 2.83–2.86 (m, 1H, 2-H), 2.47–2.57 (m,1H, 7-H), 2.02 (s, 3H, 15-H), 1.91–1.97(m, 2H, 6-H), 1.78 (s, 3H, 13-H), 1.63–1.71 (m, 4H, 1-H and 8-H), 1.56–1.60(m, 1H, 9-H), 1.35–1.42 (m, 1H, 9-H), 1.13 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d=164.9, 164.0, 153.7, 149.5, 133.0, 129.6, 129.5, 128.5, 122.4, 109.0, 49.9, 41.7, 36.2, 35.1, 32.1, 27.0, 22.7, 21.0, 20.7, 12.6. 3) High-resolution mass spectrometry characteristics of this compound: Electrospray ionization, – HRMS ((+)-ESI): m / z =360.1941 (calcd. 360.1939 for C 22 H 27 NO2Na + , [M+Na] + ). The physicochemical properties of compound C5 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.76(s, 2H, 12-H), 3.40 (q, J = 7.2 Hz, 2H, - S CH2-), 3.03–3.09 (m, 1H, 2-H), 2.77–2.80 (m, 1H, 2-H), 2.34–2.44 (m, 1H, 7-H), 1.93–2.01 (m, 2H, 6-H), 1.86 (s, 3H, 15-H), 1.77 (s, 3H, 13-H), 1.58–1.69 (m, 4H, 1-H and 8-H), 1.48–1.53 (m, 1H, 9-H), 1.44 (t, J = 7.2 Hz, 3H, - S CH2-C H 3), 1.33–1.38 (m, 1H, 9-H), 1.11 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d =165.0, 155.1, 149.2, 121.0, 109.1, 45.9, 43.5, 41.6, 35.8, 35.2, 32.0, 26.9, 22.6, 20.7, 20.4, 12.3, 8.0. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =348.1609 (calcd. 348.1609 for C 17 H 27 NO3NaS + , [M+Na] + ). The physicochemical properties of compound C6 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.76(s, 2H, 12-H), 3.30–3.34 (m, 2H, - S CH2-),3.02–3.08 (m, 1H, 2-H), 2.74–2.83 (m, 1H, 2-H), 2.33–2.43 (m, 1H, 7-H), 1.94–2.02 (m, 2H, 6-H),1.89–1.93 (m, 2H, - S CH2-C H 2-), 1.87 (s, 3H, 15-H), 1.77 (s,3H, 13-H), 1.58–1.69 (m, 4H, 1-H and 8-H), 1.46–1.53 (m, 1H,9-H), 1.33–1.39(m, 1H, 9-H), 1.11 (s, 3H, 14-H), 1.10 (t, J = 7.6 Hz, 3H, - S CH2-CH2-C H 3). – 13 CNMR (100 MHz, CDCl3): d = 164.9, 155.0, 149.3, 121.0, 109.1, 50.6, 45.9, 41.6, 35.8, 35.2, 32.0, 26.9, 22.6, 20.7, 20.5, 17.1, 12.9, 12.3. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =362.1768 (calcd. 362.1766 for C 18 H29 NO3NaS + , [M+Na] + ). The physicochemical properties of compound C7 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.60(s, 1H, Ph-H), 7.91–8.00 (m, 4H, Ph-H),7.59–7.68 (m, 2H, Ph-H), 4.71–4.73 (m, 2H, 12-H), 2.97–3.04 (m, 1H, 2-H),2.68–2.71 (m, 1H, 2-H), 2.26–2.36 (m, 1H,7-H), 1.80–1.90 (m, 2H, 6-H), 1.72(s, 6H, 15-H and 13-H), 1.53–1.65 (m, 4H, 1-H and 8-H), 1.37–1.45 (m, 1H, 9-H), 1.27–1.31 (m, 1H, 9-H), 1.03 (s, 3H,14-H). – 13 C NMR (100 MHz, CDCl3): d =164.4, 154.5, 149.3, 135.3, 132.8, 131.9, 130.8, 129.4, 129.1, 128.7, 127.9, 127.4, 123.8, 121.1, 109.0, 45.8, 41.5, 35.7, 35.1, 31.9, 26.9, 22.5, 20.6, 20.3, 12.2. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =424.1950 (calcd. 424.1946 for C 25 H 30 NO3S + [M+H] + ). The physicochemical properties of compound C8 are as follows: 1) White solid, melting point 161.3–162.7 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 9.16(dd, J = 1.6 Hz, 5.2 Hz, 1H, quinoline-H),8.58 (dd, J = 1.6 Hz, 7.2 Hz, 1H, quinoline-H), 8.26 (dd, J = 2.0 Hz, 8.4 Hz, 1H,quinoline-H), 8.12 (dd, J = 1.6, 8.4 Hz, 1H, quinoline-H), 7.69 (t, J = 7.2 Hz,1H, quinoline-H), 7.55 (dd, J = 4.2 Hz, 8.4 Hz, 1H, quinoline-H), 4.69–4.71 (m,2H, 12-H), 3.17–3.23 (m, 1H, 2-H), 2.62–2.65 (m, 1H, 2-H), 2.34–2.44 (m, 1H,7-H), 1.77–1.89 (m, 2H, 6-H), 1.70 (s, 3H, 15-H), 1.54–1.63 (m, 4H, 1-H and8-H), 1.53 (s, 3H, 13-H), 1.31–1.40 (m, 1H, 9-H), 1.24–1.28 (m,1H, 9-H), 1.01 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 164.7, 154.3, 151.9, 149.3, 144.0, 136.4, 134.6, 134.3, 133.2, 128.9, 125.1, 122.1, 121.1, 109.0, 45.8, 41.5, 35.8, 35.0, 31.8, 26.9, 22.5, 20.6, 20.5, 12.0. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =425.1901 (calcd. 425.1899 for C 24 H29 N2O3S + [M+H] + ). The physicochemical properties of compound C9 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.75(s, 2H, 12-H), 3.89 (s, 3H, -OCH3), 2.92–2.98 (m, 1H, 2-H), 2.73–2.76 (m, 1H, 2-H), 2.14–2.23 (m, 1H, 7-H), 1.88–2.00(m, 2H, 6-H), 1.84(s, 3H, 15-H), 1.77 (s, 3H, 13-H), 1.54–1.68 (m, 4H, 1-Hand 8-H), 1.41–1.49 (m, 1H, 9-H), 1.29–1.35 (m, 1H, 9-H), 1.07 (s, 3H, 14-H).– 13 C NMR (100 MHz, CDCl3): d = 156.0, 148.9, 146.7, 121.5, 107.6, 60.5, 44.9, 40.8, 35.7, 30.7, 26.1, 21.7, 19.7, 18.2, 11.2. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =248.2018 (calcd. 248.2014 for C 16 H 26 NO + [M+H] + ). The physicochemical properties of compound C10 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.75 (s, 2H, 12-H), 4.17 (t, J= 6.4 Hz, 2H, -CH2-ON), 3.50 (t, J = 8.4 Hz, 2H, CH3-OC H 2-), 3.34 (s, 3H, CH3-O-), 2.93–2.99(m, 1H, 2-H), 2.73–2.76 (m, 1H, 2-H), 2.14–2.23 (m, 1H, 7-H), 1.88–1.98 (m,4H, 6-H and 2 × CH3-O-CH2-C H 2-), 1.83 (s, 3H, 15-H), 1.76 (s, 3H, 13-H), 1.54–1.67 (m, 4H, 1-H and 8-H), 1.41–1.49 (m, 1H, 9-H), 1.28–1.33 (m, 1H, 9-H), 1.07 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 156.9, 149.9, 147.4,122.7, 108.6, 70.5, 69.8, 58.6, 46.0, 41.8, 36.7, 34.7, 31.8, 29.6, 27.1,22.7, 20.7, 19.3,12.2. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =306.2435 (calcd. 306.2433 for C 19 H 32 NO2 + [M+H] + ). The physicochemical properties of compound C11 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 4.75 (s, 2H, 12-H), 4.69 (d, J = 2.4 Hz, 2H, -O-CH2-), 2.96–3.02 (m, 1H, 2-H), 2.73–2.77 (m, 1H, 2-H), 2.45 (t, J= 2.4 Hz, 1H,≡CH), 2.18–2.27 (m, 1H, 7-H), 1.88–1.98 (m, 2H, 6-H), 1.84 (s,3H, 15-H), 1.76 (s, 3H, 13-H), 1.55–1.67 (m, 4H, 1-H and 8-H), 1.43–1.50 (m, 1H, 9-H), 1.28–1.33 (m, 1H, 9-H), 1.07 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d =157.8, 148.8, 147.5, 121.4, 107.7, 79.3, 72.8, 60.2, 44.9, 40.8, 35.5, 33.7, 30.7, 26.1, 21.7, 19.7, 18.4, 11.2. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =272.2014 (calcd. 272.2014 for C 18 H 26 NO + [M+H] + ). The physicochemical properties of compound C12 are as follows: 1) Pale yellow solid, melting point 73.6–74.5 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.51 (s, 1H, - N H-), 7.70 (d, J= 2.4 Hz, 1H, Ph-H), 7.34–7.40 (m, 2H, Ph-H), 4.78 (s, 2H, 12-H), 3.13–3.20 (m, 1H, 2-H), 2.77–2.86 (m, 1H, 2-H), 2.39–2.49 (m, 1H, 7-H), 1.97–2.04 (m, 2H, 6-H), 1.91 (s,3H, 15-H), 1.79 (s, 3H, 13-H), 1.59–1.72 (m, 4H, 1-H and 8-H), 1.49–1.56(m,1H, 9-H), 1.35–1.41 (m, 1H, 9-H), 1.13 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 162.1, 155.2, 152.3, 149.3, 136.8, 132.8, 130.5, 127.2, 121.0, 118.7, 109.1, 45.9, 41.6, 35.9, 35.2, 32.1, 26.9, 22.6, 20.8, 20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =443.1273 (calcd. 443.1269 for C 22 H 26 N2O2Na 35 Cl2 + , [M+Na] + ); 445.1248 (calcd.445.1244 for C 22 H 26 N2O2Na 35 Cl 37 Cl + , [M+Na] + ); 446.1256 (calcd. 446.1261 forC 22 H 26 N2O2Na 37 Cl2 + , [M+Na] + ). The physicochemical properties of compound C13 are as follows: 1) White solid, melting point 120.6–121.7 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.47 (s, 1H, - N H-), 7.39–7.46 (m, 4H, Ph-H), 4.78 (s, 2H, 12-H), 3.14–3.21 (m, 1H, 2-H), 2.77–2.86 (m, 1H, 2-H), 2.39–2.48(m,1H, 7-H), 1.97–2.05 (m, 2H, 6-H), 1.91 (s, 3H, 15-H), 1.78 (s, 3H, 13-H), 1.59–1.71 (m, 4H, 1-H and 8-H), 1.49–1.56 (m, 1H, 9-H), 1.35–1.41 (m, 1H, 9-H),1.12 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 161.9, 154.9, 152.5, 149.3, 135.8, 129.1, 121.2, 120.7, 109.1, 46.0, 41.6, 36.0, 35.2, 32.1, 27.0, 22.7, 20.8, 20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =431.1335 (calcd. 431.1334 for C 22 H 28 N2O2 79 Br + [M+H] + ); 433.1317 (calcd.433.1316 for C 22 H 28 N2O2 81 Br + [M+H] + ). The physicochemical properties of compound C14 are as follows: 1) Yellow solid, melting point 137.1–139.7 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1H NMR (400MHz, CDCl3): d = 8.71 (s, 1H, - N H-), 7.31 (t, J = 2.4 Hz, 1H, Ph-H), 7.95–7.99 (m, 2H, Ph-H), 7.54 (t, J = 8.0 Hz, 1H, Ph-H), 4.79 (s, 2H, 12-H), 3.16–3.22 (m, 1H, 2-H), 2.79–2.87 (m, 1H, 2-H), 2.42–2.51 (m,1H, 7-H), 1.98–2.02 (m, 2H, 6-H), 1.94 (s, 3H, 15-H), 1.79 (s, 3H, 13-H), 1.64–1.72 (m,4H, 1-H and 8-H), 1.53–1.58 (m, 1H, 9-H), 1.36–1.42 (m, 1H, 9-H),1.25 (s, 3H,14-H). – 13 C NMR (100 MHz, CDCl3): d = 162.4, 155.5, 152.4, 149.3, 148.6, 138.5, 129.9, 125.1, 121.0, 118.6, 114.2, 109.2, 45.9, 35.9, 35.2, 32.1, 26.9, 22.6, 20.8, 20.7, 12.6. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =398.2076 (calcd. 398.2080 for C 22 H 28 N3O4 + [M+H] + ). The physicochemical properties of compound C15 are as follows: 1) White solid, melting point 114.5–115.2 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.72 (s, 1H, - NH-), 7.64 (s, 4H, Ph-H), 4.78 (s, 2H, 12-H), 3.14–3.20 (m, 1H, 2-H), 2.78–2.86 (m, 1H, 2-H), 2.40–2.50 (m,1H,7-H), 1.98–2.04 (m, 2H, 6-H), 1.92 (s, 3H, 15-H), 1.79 (s, 3H, 13-H), 1.60–1.72 (m, 4H, 1-H and 8-H), 1.50–1.57 (m, 1H, 9-H), 1.35–1.42 (m, 1H, 9-H), 1.13 (s,3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 162.3, 155.5, 152.0,149.2, 141.3, 133.3, 120.9, 119.2, 118.8, 109.2, 106.9, 45.9,41.6, 35.9,35.2, 32.1, 26.9, 22.6, 20.8, 20.6, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =400.1997 (calcd. 400.2001 for C 23 H 27 N3O2Na + , [M+Na] + ). The physicochemical properties of compound C16 are as follows: 1) Pale yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.46(s, 1H, - N H-), 7.51 (d, J = 7.6 Hz, 2H, Ph-H), 7.5 (t, J = 8.0 Hz, 2H, Ph-H), 7.13 (t, J= 14.8 Hz, 1H, Ph-H), 4.78 (s, 2H,12-H), 3.16–3.22 (m, 1H, 2-H), 2.77–2.86 (m, 1H, 2-H), 2.39–2.49 (m, 1H, 7-H), 1.97–2.01 (m, 2H, 6-H), 1.92 (s, 3H, 15-H), 1.78 (s, 3H, 13-H), 1.59–1.69 (m, 4H, 1-H and 8-H), 1.52–1.56 (m, 1H, 9-H), 1.37–1.41 (m, 1H, 9-H), 1.13(s, 3H,14-H). – 13 C NMR (100 MHz, CDCl3): d = 161.6, 154.5, 152.6, 149.4, 137.2, 129.0, 124.0, 121.3, 119.5, 109.1, 45.9, 41.6, 36.0, 35.1, 32.1, 27.0, 22.6, 20.7, 20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =369.1996 (calcd. 369.2001 for C 22 H 29 N2OS + [M+H] + ). The physicochemical properties of compound C17 are as follows: 1) Pale yellow solid, melting point 102.2–103.7 ℃; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.42(s, 1H, - NH-), 7.43–7.48 (m, 2H, Ph-H), 7.00–7.06 (m, 2H, Ph-H), 4.78 (s, 2H, 12-H), 3.15–3.22 (m, 1H, 2-H), 2.77–2.86 (m, 1H, 2-H), 2.39–2.49 (m,1H, 7-H), 1.97–2.05 (m, 2H, 6-H), 1.92 (s,3H, 15-H), 1.78 (s, 3H, 13-H), 1.62–1.72 (m, 4H, 1-H and 8-H), 1.48–1.56 (m,1H, 9-H), 1.35–1.41 (m, 1H, 9-H),1.13 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 161.8, 160.5 ( J CF = 241.6 Hz), 154.7, 152.9, 149.3, 133.2 ( J CCCF = 2.7Hz), 121.5 ( J CCCF = 7.8 Hz), 121.2, 115.8 ( J CCF = 22.4 Hz), 109.1, 45.9, 41.6, 36.0, 35.2, 32.1, 26.9, 22.6, 20.7, 20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =387.1899 (calcd. 387.1906 for C 22 H 28 N2OFS + [M+H] + ). The physicochemical properties of compound C18 are as follows: 1) Yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 8.47(s, 1H, - N H-), 7.46 (d, J= 8.8 Hz, 2H, Ph-H), 7.31 (d, J = 8.8 Hz, 2H, Ph-H), 4.78 (s, 2H, 12-H), 3.14–3.21 (m, 1H, 2-H), 2.77–2.86 (m,1H, 2-H), 2.39–2.48 (m, 1H, 7-H), 1.97–2.04 (m, 2H, 6-H), 1.92(s, 3H, 15-H), 1.78 (s, 3H, 13-H), 1.63–1.69 (m, 4H, 1-H and 8-H), 1.51–1.56(m, 1H, 9-H), 1.35–1.41 (m, 1H, 9-H), 1.12 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d = 161.9, 154.9, 152.6, 149.3, 135.8, 129.1, 121.2, 120.7, 109.1, 46.0, 41.6, 36.0, 35.2, 32.1, 27.0, 22.7, 20.8, 20.7, 12.5. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =425.1432 (calcd. 425.1430 for C 22 H 27 N2ONaS 35 Cl + , [M+Na] + ); 427.1381 (calcd.427.1379 for C 22 H 27 N2ONaS 37 Cl + , [M+Na] + ). The physicochemical properties of compound C19 are as follows: 1) Yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d= 9.56(s, 1H, -CHO), 6.34 (s, 1H, 12-H), 6.06(s, 1H, 12-H), 2.75–2.79 (m, 1H, 2-H), 2.58–2.66 (m, 1H, 2-H), 2.48–2.55 (m,1H, 7-H), 2.38–2.44 (m, 1H, 6-H), 2.02–2.09 (m, 1H, 6-H), 1.78–1.87 (m, 2H, 1-H), 1.77 (d, J = 1.2 Hz, 3H, 15-H), 1.70–1.72 (m, 2H, 8-H), 1.64–1.69 (m, 1H,9-H), 1.47–1.54 (m, 1H, 9-H), 1.25 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d =199.0, 194.1, 160.7, 153.7, 133.2, 129.2, 41.6, 37.3, 36.9, 35.7, 33.7, 32.5, 26.6, 22.4, 10.9. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =233.1544 (calcd. 233.1542 for C 15 H 21 O2 + [M+H] + ). The physicochemical properties of compound C20 are as follows: 1) Yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d= 5.24(s, 1H, 12-H), 5.10 (s, 1H, 12-H), 4.13(s, 2H, 13-H), 2.82–2.87 (m, 1H, 2-H), 2.48–2.53 (m, 1H, 2-H), 2.42–2.44 (m,1H, 7-H), 2.26–2.33 (m, 1H, 6-H), 2.03–2.10 (m, 1H, 6-H), 1.81–1.88 (m, 2H, 1-H), 1.79 (d, J = 1.2 Hz, 3H, 15-H), 1.67–1.71 (m, 2H, 8-H), 1.61–1.65 (m, 1H,9-H), 1.47–1.51 (m, 1H, 9-H), 1.23 (s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d =199.0, 161.1, 148.8, 129.1, 113.9, 47.5, 41.8, 41.3, 37.3, 35.8, 33.7, 33.2, 27.3, 22.4, 10.9. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =253.1360 (calcd. 253.1359 for C 15 H 22 O 35 Cl + [M+H] + ); 255.1335 (calcd. 255.1334for C 15 H 22 O 37 Cl + [M+H] + ). The physicochemical properties of compound C21 are as follows: 1) Yellow liquid; 2) NMR spectral characteristics of this compound: using deuterated chloroform as solvent and TMS as internal standard, the peaks are assigned as follows: – 1 H NMR (400 MHz, CDCl3): d = 5.28(s, 1H, 12-H), 5.10 (s, 1H, 12-H), 4.05(s, 2H, 13-H), 2.88 (d, J= 14.4 Hz, 1H, 2-H), 2.48–2.57 (m, 1H, 2-H), 2.38–2.44 (m, 1H, 7-H), 2.29–2.36 (m, 1H,6-H), 2.04–2.11 (m, 1H, 6-H), 1.82–1.86(m, 2H, 1-H), 1.79 (s, 3H, 15-H), 1.69–1.76 (m, 2H, 8-H), 1.62–1.66 (m, 1H,9-H), 1.45–1.52 (m, 1H, 9-H), 1.24(s, 3H, 14-H). – 13 C NMR (100 MHz, CDCl3): d =199.0, 161.1, 149.1, 129.1, 114.5, 41.8, 37.3, 35.9, 35.8, 33.8, 33.3, 27.4,22.4, 11.0. 3) High-resolution mass spectrometry characteristics of the compound: Electrospray ionization was performed, – HRMS ((+)-ESI): m / z =297.0852 (calcd. 297.0854 for C 15 H 22 O 79 Br + [M+H] + ); 299.0836 (calcd. 299.0838for C 15 H 22 O 81 Br + [M+H] + ). Antibacterial activity assay: 1. Tested plant pathogenic fungi: *Gray mold of tomato* ( Botrytis cinerea ), tomato early blight pathogen ( Alternaria solani Fusarium solani ( ), Fusarium solani ), Fusarium wilt of watermelon ( Fusarium oxysporum ), wheat scab ( Fusarium graminearum ) and millet blast fungus ( Pyricularia gray sea ).
[0025] 2. Test samples and reagents: Test samples: α-cyperone and the α-cyperone derivatives C1–C21 prepared above.
[0026] Control agents: 99% oxadixyl and 98% difenoconazole technical grade.
[0027] Solvent: Acetone (analytical grade), emulsifier: Tween-80 (analytical grade).
[0028] 3. Antibacterial activity test methods and results: (1) The inhibitory effect of the α-cyperone derivative prepared above on the mycelial growth of six plant pathogenic fungi was tested using the mycelial growth rate assay. The specific method was as follows: all test samples were dissolved in acetone and mixed with melted PDA medium, then poured into sterile petri dishes to prepare a drug-containing medium with a concentration of 150 μg / mL (the acetone content in the drug-containing medium did not exceed 0.5%). v / v After the culture medium cooled and solidified, the pre-activated test strain was broken into 4 mm diameter mycelial discs along the edge of the colony and inoculated into the center of the drug-containing culture medium. Each drug was repeated three times. A blank control without the drug and a positive control with the same concentration of hymexazol were also set up. The cultures were incubated at a suitable temperature until the colony diameter of the blank control group reached 2 / 3 of the petri dish diameter. The colony diameter of each treatment group and the control group was measured using the cross-sectional method. The mycelial growth inhibition rate of each drug treatment group was calculated according to Formula 1, and the corresponding standard deviation was also calculated. The results are shown in Table 1.
[0029] Table 1. Inhibitory activity of α-cyperone derivatives C1–C21 against the hyphal growth of six plant pathogenic fungi. Table 1 shows that at the tested concentration of 150 μg / mL, derivatives C1, C2, C5, C19, and C20 exhibited strong inhibitory effects on mycelial growth against *Botrytis cinerea*, the causal agent of tomato gray mold, with inhibition rates all exceeding 80%, superior to the parent agent α-cyperone and the positive control agent oxadixyl. Derivatives C1 and C19, in particular, achieved inhibition rates as high as 94.7% and 98.9%, respectively. Derivatives C1, C2, and C19 showed the most significant inhibitory activity against *Early Blight*, the causal agent of tomato early blight, with inhibition rates of 81.5%, 85.1%, and 88.3%, respectively, significantly better than the parent agent α-cyperone and the control agent oxadixyl. Derivatives C1, C19, and C20 exhibited good inhibitory activity against *Fusarium solani*, with inhibition rates all exceeding 70%, superior to α-cyperone and oxadixyl. Compounds C1, C19, and C20 exhibited significant antifungal activity against *Fusarium wilt*, the causal agent of watermelon wilt, with inhibition rates all around 80%, superior to α-cyperone and oxadixyl. Derivatives C1, C2, and C20 showed the best antifungal activity against *Fusarium graminearum*, particularly compound C1, which achieved a 90.1% inhibition rate, far exceeding the parent compound α-cyperone and the positive control agent oxadixyl. Furthermore, derivatives C1, C2, and C19 all showed inhibition rates exceeding 75% against *Bacillus thuringiensis*, the causal agent of millet blast, significantly better than α-cyperone and oxadixyl.
[0030] In summary, most of the tested derivatives showed some inhibitory effect against the six plant pathogens. Derivatives C1, C19, and C20, in particular, exhibited the most significant antibacterial activity, showing strong inhibitory effects on the hyphae of all six tested plant pathogens. This indicates that they possess broad-spectrum and highly efficient antibacterial activity, and therefore hold promise for further development in the preparation of novel agricultural antibacterial agents.
[0031] (2) The inhibitory activity of the α-cyperone derivative prepared above against the spores of four plant pathogenic fungi was tested using the spore germination method. The specific implementation steps were as follows: the pathogens were cultured on PDA medium for 2 weeks, then the colonies were gently scraped off with a scraper, rinsed with sterile water, filtered through double-layer gauze to remove hyphae and medium, washed repeatedly with sterile water 3 times, and finally diluted with sterile water to the required spore concentration (approximately 20-40 spores per field of view under a 100x microscope) to obtain the spore suspension; the sample to be tested was dissolved in a certain amount of DMSO, diluted with 0.1% Tween-80 sterile aqueous solution to a stock solution of 1 mg / mL, and then 5-7 series of mass concentrations were set, with the final organic solvent content not exceeding 2% (v / v); the prepared sample solution and the spore suspension were mixed evenly in equal volumes to obtain the required final concentration. 2% DMSO plus 0.1% Tween-80 sterile aqueous solution was used as the solvent control group. The above mixture was pipetted onto a concave glass slide using a micropipette. The slide was then placed in a petri dish with a shallow layer of water, covered, and incubated in a suitable temperature incubator. The germination of spores on the slide was observed under a microscope. Germination was considered complete when the germ tube of the spore was larger than the short radius of the spore. When the germination rate of the blank control spores was greater than 90%, the germination status of each group was observed and statistically analyzed. The spore germination inhibition rate and corrected spore germination inhibition rate of each treatment group were calculated using Formulas 2 and 3. The median inhibitory concentration and 95% confidence interval for each sample against different fungal spores were also determined. The results are shown in Table 2.
[0032] Table 2. Inhibitory effects of α-cyperone derivatives C1–C21 on spore germination of four plant pathogenic fungi. Table 2 shows that derivatives C1, C2, C5, C19, and C20 exhibited particularly strong inhibitory effects on the germination of *Botrytis cinerea* spores, with median inhibitory concentrations of 1.7, 2.0, 9.2, 7.4, and 1.4 µg / mL, respectively. Their inhibitory activities were significantly higher than the parent compound α-cyperone and far superior to the positive control, difenoconazole. Derivatives C1, C2, C20, and C21 showed the most prominent inhibitory activities against *Early Blight* spores, with median inhibitory concentrations of 2.1, 4.3, 2.7, and 6.5 µg / mL, respectively, all superior to the commercially available difenoconazole, demonstrating strong application potential. The median inhibitory concentrations of derivatives C1, C2, C16, C19, and C20 against *Fusarium solani* spores were 9.6, 7.2, 8.3, 7.1, and 6.5 µg / mL, respectively. The inhibitory activity of the derivatives C1 and C20 against watermelon wilt spores was 6.5 µg / mL and 4.8 µg / mL, respectively, which were significantly higher than those of α-cyperone and difenoconazole.
[0033] In summary, some of the α-cyperone derivatives prepared in this invention have strong inhibitory activity against the germination of plant pathogenic fungal spores. In particular, derivatives C1 and C20 show highly efficient and broad-spectrum inhibitory effects, and thus are expected to be used to prepare novel agricultural fungal spore germination inhibitors.
Claims
1. An α-cyperone derivative, characterized in that, The α-cyperone derivative is selected from any one of the oxime derivatization products, halogen-substituted products, and aldehyde-substituted products of α-cyperone.
2. The α-cyperone derivative according to claim 1, characterized in that, The oxime derivatization products include oxime ethers and oxime esters; the oxime esters are carboxylic acid oxime esters, sulfonic acid oxime esters, carbamate oxime esters, or thiocarbamate oxime esters.
3. The α-cyperone derivative according to claim 1, characterized in that, The halogen-substituted product is a chlorinated derivative or a bromine derivative.
4. The α-cyperone derivative according to claim 1, characterized in that, The general chemical formula of the α-cyperone derivative is shown in formula (I): Equation (I) Formula (I)R 1 It is any one of the following: In equation (Ⅰ), R 1 and R 2 It is any of the following: 。 5. A method for preparing an α-cyperone derivative as described in any one of claims 1-4, characterized in that, Starting from α-cyperone, α-cyperone derivatives are prepared by at least one of the following three types of reactions: Oxime derivatization reaction: First, α-cyperone is oximated to obtain α-cyperone oxime intermediate, and then the intermediate is esterified or etherified to prepare oxime esters and oxime ether derivatives. Oxidative aldehyde reaction: The oxidant directly oxidizes the α-cyperone core to obtain aldehyde derivatives; Halogenation substitution reaction: α-Cyperone undergoes substitution with halogenated reagents to yield chlorinated and brominated derivatives.
6. The method for preparing an α-cyperone derivative according to claim 5, characterized in that, The oxime derivatization reaction steps are as follows: α-Cyperone is reacted with hydroxylamine hydrochloride in an alcohol solvent to obtain an α-cyperone oxime intermediate; the intermediate is reacted with substituted acyl chlorides and sulfonyl chlorides in an organic base combined with a haloalkane solvent to obtain carboxylic acid oxime ester derivatives C1–C4 and sulfonate oxime ester derivatives C5–C8; the intermediate is reacted with haloalkanes in a strong base combined with an ether solvent to obtain α-cyperone oxime ether derivatives C9–C11; the intermediate is condensed with substituted isocyanates and isothiocyanates in a ketone solvent to obtain carbamate oxime ester derivatives C12–C15 and thiocarbamate oxime ester derivatives C16–C18, respectively. The oxidative aldehyde reaction step is as follows: using 1,4-dioxane as a solvent, selenium dioxide is used to oxidize α-cyperone to obtain the aldehyde derivative C19. The halogenation substitution reaction steps are as follows: using tetrahydrofuran as a solvent, α-cyperone reacts with trichloroisocyanuric acid to prepare chloro-α-cyperone C20; using dichloromethane as a solvent, α-cyperone reacts with... N -Brominated succinimide reaction to prepare bromo derivative C21.
7. The method for preparing an α-cyperone derivative according to claim 6, characterized in that, The organic base is triethylamine, the haloalkane solvent is dichloromethane, the strong base is sodium hydride, the ether solvent is tetrahydrofuran, and the ketone solvent is acetone.
8. The method for preparing an α-cyperone derivative according to claim 7, characterized in that, Specifically, the following steps are included: 1.0 mmol of α-cyperone, 3.0 mmol of hydroxylamine hydrochloride, and 12.5 mmol of pyridine were dissolved in anhydrous ethanol and reacted at room temperature. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was concentrated under reduced pressure, water was added and stirred, and the pH of the mixture was adjusted to neutral with saturated sodium bicarbonate solution. The mixture was extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain the α-cyperone oxime intermediate. 0.5 mmol of α-cyperone oxime intermediate and 1.5 mmol of triethylamine were dissolved in anhydrous dichloromethane. 0.6 mmol of the corresponding substituted acyl chloride or sulfonyl chloride was slowly added dropwise. The mixture was stirred at room temperature, and the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction solution was concentrated under reduced pressure. The residue was purified by preparative thin-layer chromatography to obtain α-cyperone carboxylic acid oxime ester derivatives C1–C4 or sulfonate oxime ester derivatives C5–C8. 0.5 mmol of the α-cyperone oxime intermediate was dissolved in anhydrous tetrahydrofuran, and 2.0 mmol of sodium hydride was added and stirred at room temperature. Then, 2.0 mmol of the corresponding haloalkane was added to the reaction solution and reacted under reflux. The reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was naturally cooled to room temperature, concentrated under reduced pressure to remove the solvent, water was added to the residue and stirred, and the pH of the mixture was adjusted to neutral with 1 M dilute hydrochloric acid aqueous solution. The mixture was then extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and purified by preparative thin-layer chromatography to obtain α-cyperone oxime ether derivatives C9–C11. 0.5 mmol of α-cyperone intermediate was dissolved in acetone, and 0.6 mmol of the corresponding substituted isocyanate or isothiocyanate was added to the reaction solution. The reaction was stirred under reflux, and the reaction progress was monitored by thin-layer chromatography. After the reaction was completed, the reaction solution was naturally cooled to room temperature, and the solvent was removed by concentration under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain carbamate oxime derivatives C12–C15 or thiocarbamate oxime derivatives C16–C18. 0.5 mmol of α-cyperone and 0.8 mmol of selenium dioxide were stirred in 1,4-dioxane at room temperature. After the reaction was completed, the reaction solution was concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain aldehyde compound C19. 0.5 mmol of α-cyperone and 0.5 mmol of trichloroisocyanuric acid were dissolved in anhydrous tetrahydrofuran and stirred at -15°C. After the reaction was complete, the reaction solution was concentrated under reduced pressure. The crude product was purified by preparative thin-layer chromatography to obtain chloro-α-cyperone C20. 0.5 mmol of α-cyperone and N 0.8 mmol of α-bromosuccinimide was refluxed in anhydrous dichloromethane. After the reaction was complete, the reaction solution was cooled to room temperature, concentrated under reduced pressure to remove the solvent, and the residue was purified by preparative thin-layer chromatography to obtain α-bromocyperone C21.
9. The application of an α-cyperone derivative as described in any one of claims 1-4, characterized in that, The α-cyperone derivative or its pharmaceutically acceptable salt can be used in the preparation of bactericides.
10. The application of an α-cyperone derivative according to claim 9, characterized in that, The fungicide can be used against any one of the following plant pathogenic fungi: gray mold of tomato, early blight of tomato, Fusarium solani, wilt of watermelon, Fusarium graminearum of wheat, or blast fungus of millet.
